Antibacterial Effect of Curcuma longa (Turmeric) Against Staphylococcus aureus and Escherichia coli. 2015

R Afrose, and S K Saha, and L A Banu, and A U Ahmed, and A S Shahidullah, and A Gani, and S Sultana, and M R Kabir, and M Y Ali
Dr Rafika Afrose, M Phil Student (Thesis), Department of Pharmacology, Mymensingh Medical College, Mymensingh, Bangladesh.

This observational study was conducted during the period from July 2010 to June 2011 in the Department of Pharmacology in the collaboration of Department of Microbiology, Mymensingh Medical College, Mymensingh to determine the profile of antibacterial effect of Crude Turmeric paste aqueous turmeric extract, and standard antibiotic Amikacin against Staphylococcus aureus and Escherichia coli. Three separate experiments were done e.g. (Expt- I) Inhibitory effect of Crude Turmeric paste incorporated into nutrient agar (NA) media, (Expt- II) Minimum inhibitory concentration of (a) Aqueous Turmeric extract and (b) Amikacin by broth dilution technique and (Expt-III) their subculture study in nutrient agar (NA) media for confirmation of respective results of previous experiments. Inhibitory effects were observed against the growth of Staph Aureus and Esch coli at 10% and 30% respectively of Crude Turmeric paste incorporated into NA media. The broth dilution technique was followed to determine the MIC of Aqueous Turmeric extract and Amikacin. The MIC of Aqueous Turmeric extract was 800 μg/ml against Staph aureus and that against Esch coli was 2000 μg/ml and the MIC of Amikacin was 10 μg/ml for both the bacteria. The MIC of Amikacin was the lowest in comparison to MIC of Aqueous Turmeric extract for complete inhibition of growth of Staph aureus and Esch coli. The subculture study showed similar results with that of previous experiments in terms of inhibitory effects of Crude Turmeric paste and MIC of Aqueous Turmeric extract and Amikacin against all of the organisms studied.

UI MeSH Term Description Entries
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000583 Amikacin A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics. A.M.K,Amikacin Sulfate,Amikacina Medical,Amikacina Normon,Amikafur,Amikalem,Amikason's,Amikayect,Amikin,Amiklin,Amukin,BB-K 8,BB-K8,Biclin,Biklin,Gamikal,Kanbine,Oprad,Yectamid,BB K 8,BB K8,BBK 8,BBK8,Medical, Amikacina,Normon, Amikacina,Sulfate, Amikacin
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D030024 Curcuma A plant genus of the family ZINGIBERACEAE that contains CURCUMIN and curcuminoids. Tumeric,Turmeric,Zedoary zedoaria,Curcuma longa,Curcuma zedoaria,Curcuma longas,Curcuma zedoarias,Curcumas,Tumerics,Turmerics,Zedoary zedoarias,longa, Curcuma,zedoaria, Curcuma,zedoaria, Zedoary

Related Publications

R Afrose, and S K Saha, and L A Banu, and A U Ahmed, and A S Shahidullah, and A Gani, and S Sultana, and M R Kabir, and M Y Ali
July 2005, Phytotherapy research : PTR,
R Afrose, and S K Saha, and L A Banu, and A U Ahmed, and A S Shahidullah, and A Gani, and S Sultana, and M R Kabir, and M Y Ali
December 1997, The Journal of laboratory and clinical medicine,
R Afrose, and S K Saha, and L A Banu, and A U Ahmed, and A S Shahidullah, and A Gani, and S Sultana, and M R Kabir, and M Y Ali
September 2001, Alternative medicine review : a journal of clinical therapeutic,
R Afrose, and S K Saha, and L A Banu, and A U Ahmed, and A S Shahidullah, and A Gani, and S Sultana, and M R Kabir, and M Y Ali
September 2021, Archives of microbiology,
R Afrose, and S K Saha, and L A Banu, and A U Ahmed, and A S Shahidullah, and A Gani, and S Sultana, and M R Kabir, and M Y Ali
June 2015, Biotechnology reports (Amsterdam, Netherlands),
R Afrose, and S K Saha, and L A Banu, and A U Ahmed, and A S Shahidullah, and A Gani, and S Sultana, and M R Kabir, and M Y Ali
January 2020, PeerJ,
R Afrose, and S K Saha, and L A Banu, and A U Ahmed, and A S Shahidullah, and A Gani, and S Sultana, and M R Kabir, and M Y Ali
November 2018, Pakistan journal of pharmaceutical sciences,
R Afrose, and S K Saha, and L A Banu, and A U Ahmed, and A S Shahidullah, and A Gani, and S Sultana, and M R Kabir, and M Y Ali
October 2022, International journal of environmental research and public health,
R Afrose, and S K Saha, and L A Banu, and A U Ahmed, and A S Shahidullah, and A Gani, and S Sultana, and M R Kabir, and M Y Ali
February 1971, Journal of pharmaceutical sciences,
R Afrose, and S K Saha, and L A Banu, and A U Ahmed, and A S Shahidullah, and A Gani, and S Sultana, and M R Kabir, and M Y Ali
January 2013, International journal of biological macromolecules,
Copied contents to your clipboard!